These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8415777)

  • 1. Chronic effects of camostate on growth and endocrine function of the pancreas in streptozotocin-induced diabetic rats.
    Kogire M; Inoue K; Gu Y; Uchida K; Imamura M
    Proc Soc Exp Biol Med; 1993 Nov; 204(2):201-5. PubMed ID: 8415777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.
    Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG
    Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.
    von Schönfeld J; Rünzi M; Goebell H; Müller MK
    Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
    Otsuki M; Ohki A; Okabayashi Y; Suehiro I; Baba S
    Pancreas; 1987; 2(2):164-9. PubMed ID: 3628222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of trypsin inhibitor on the pancreas and small intestine of mice.
    Ge YC; Morgan RG
    Br J Nutr; 1993 Jul; 70(1):333-45. PubMed ID: 8399113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
    Lhoste EF; Roebuck BD; Longnecker DS
    Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas.
    Göke B; Siegel EG; Stöckmann F; Lankisch PG; Creutzfeldt W
    Digestion; 1985; 31(2-3):128-35. PubMed ID: 3888752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats.
    Kisfalvi K; Friess H; Büchler MW; Tulassay Z; Varga G; Papp M
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):69-74. PubMed ID: 8900912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
    Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
    Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
    Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH
    Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
    Miyasaka K; Nakamura R; Kitani K
    J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats.
    Göke B; Fenchel K; Knobloch S; Arnold R; Adler G
    Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
    Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
    Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
    Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate).
    Göke B; Printz H; Koop I; Rausch U; Richter G; Arnold R; Adler G
    Pancreas; 1986; 1(6):509-15. PubMed ID: 3562444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a low-molecular weight serine proteinase inhibitor (camostate) on amylase release from isolated pancreatic acini.
    Göke B; Leferink J; Göke R; Adler G
    Res Exp Med (Berl); 1989; 189(1):33-8. PubMed ID: 2469115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
    Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
    Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of oral synthetic protease inhibitor (FOY 305) on endocrine pancreas and carbohydrate and lipid metabolism in normal and streptozotocin-induced diabetic rats].
    Eto M; Watanabe K; Kagaya T; Sakai Y; Yoshida S; Oyama K; Futaki G; Saito T; Takebe T; Ishii K
    Nihon Naibunpi Gakkai Zasshi; 1984 May; 60(5):684-95. PubMed ID: 6386547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats.
    Löser C; Fölsch UR; Cleffmann U; Nustede R; Creutzfeldt W
    Digestion; 1989; 43(1-2):98-112. PubMed ID: 2509268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.